Skip to main content

Year: 2023

SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results

EDEN PRAIRIE, MN, Nov. 08, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, November 10, 2023, at 8:00AM (ET) to present the Q3 2023 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Listening: 1-877-407-0784 or 1-201-689-8560 Conference ID number : 13742652 OR click the Call me™ link for instant telephone access to the event.https://callme.viavid.com/viavid/?callme=true&passcode=13732361&h=true&info=company&r=true&B=6 Participants can use Guest dial-in #s above and be answered by an operator OR click the Call me™ link for instant telephone access to the event. A replay will be made available...

Continue reading

CNH Industrial: Completion of $300 million Buyback Program

Basildon, November 8, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that it has completed its sixth and final $50 million tranche (the “Sixth Tranche”) of its $300 million share buyback program. The Company completed transactions in the period October 30 through November 6, 2023, reported in aggregate, based on automatic orders placed with the Company’s broker (who has made its trading decisions as to the timing of the purchases independently of the Company and on the basis of instructions given before the commencement of the Company’s closed period under the applicable regulations) as set forth in the table below. After the purchases announced today and considering those previously executed under the Sixth Tranche, the total invested amount in the Sixth Tranche is approximately €46,768,174.09 ($50,000,004.01) or a total...

Continue reading

Disc Medicine to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at the Stifel 2023 Healthcare Conference on Wednesday, November 15th at 11:30 am ET. Disc will also give presentations at the Jefferies London Healthcare Conference on Thursday, November 16th at 9:30 am GMT / 4:30 am ET and the Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30th at 2:30 pm ET. A live webcast of the presentations will be available through the investor relations section of the Company’s website at ir.discmedicine.com and an archived replay will be...

Continue reading

WEST MINING ANNOUNCES PROPOSED SHARE CONSOLIDATION

Vancouver, BC, Nov. 08, 2023 (GLOBE NEWSWIRE) — West Mining Corp. (“West” or the “Company”) (CSE: WEST) (OTC: WESMF) announces that it will complete a consolidation of the authorized and issued common shares of the Company (the “Common Shares”) on the basis of a one post-consolidated Common Share for each ten pre-consolidation Common Shares (the “Consolidation”). Prior to the Consolidation, the Company has 61,627,312 pre-Consolidation Common Shares issued and outstanding. Following the Consolidation, the Company will have approximately 6,162,731 post-Consolidation Common Shares issued and outstanding. No fractional Common Shares will be issued upon the Consolidation. In the event a holder of Common Shares would otherwise be entitled to receive a fractional Common Share in connection with the Consolidation, the number of Common...

Continue reading

BurgerFi to Report Third Quarter 2023 Financial Results on November 15, 2023

FORT LAUDERDALE, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of the nation’s leading fast-casual “better burger” dining concepts through the BurgerFi brand, and the high-quality, casual dining pizza brand under the name Anthony’s Coal Fired Pizza & Wings (“Anthony’s”), will report financial results for the third quarter ended October 2, 2023 on Wednesday, November 15, 2023 before the market opens. Management will host a conference call at 8:30 a.m. Eastern time on the same day to discuss the results.   The conference call will be broadcast live and available for replay on the Company’s Investor Relations website at ir.burgerfi.com. Participants can also access the call using the dial-in details below. Date: Wednesday, November 15, 2023Time: 8:30 a.m. ETToll-free...

Continue reading

RadNet Reports Third Quarter Financial Results and Revises Upwards 2023 Financial Guidance Range for Adjusted EBITDA

Consolidated Revenue increased 14.8% to $402.0 million in the third quarter of 2023 from $350.0 million in the third quarter of 2022; Excluding Revenue from our Artificial Intelligence (“AI”) reporting segment, Revenue from the Imaging Centers reporting segment in the third quarter of 2023 was $399.1 million, an increase of 14.3% from last year’s third quarter of $349.1 million Excluding losses from our AI reporting segment, Adjusted EBITDA(1) from the Imaging Centers reporting segment was $60.4 million in the third quarter of 2023 as compared with $50.2 million in the third quarter of 2022, an increase of 20.3% After adjusting for certain unusual or one-time items impacting the quarters and AI pre-tax losses, Adjusted Earnings(3) was $9.9 million and diluted Adjusted Earnings Per Share(3) was $0.14 for the third quarter of 2023 as compared...

Continue reading

Agrify Receives Extended Stay of Suspension from Nasdaq

TROY, Mich., Nov. 08, 2023 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq: AGFY) (“Agrify”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that on November 6, 2023 it received a letter from the Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying Agrify that the stay of suspension for Agrify’s common stock will be extended until a hearing before the Panel and issuance of a final Panel decision. As previously reported, on October 17, 2023, Nasdaq staff notified Agrify (the “Staff Determination”) that it had initiated a process that could result in the delisting of Agrify’s securities from Nasdaq as a result of Agrify not being in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely...

Continue reading

Alimera Appoints Maggie A. Pax to Its Board of Directors

Maggie A. PaxMaggie A. Pax Appointed to Board of Directors of Alimera SciencesATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces the addition of Maggie A. Pax to its Board of Directors. Ms. Pax presently serves on the board of several life sciences companies. “Maggie’s experience within growing companies, leading product development, business strategy, supply chain, and commercial teams, along with leading the development of business partnerships, will bring additional operational experience to our board,” said Rick Eiswirth, Alimera’s President and Chief Executive Officer. “Her leadership in companies...

Continue reading

Intrepid Announces Third Quarter 2023 Results

Denver, CO, Nov. 08, 2023 (GLOBE NEWSWIRE) — Intrepid Potash, Inc. (“Intrepid”, the “Company”, “we”, “us”, “our”) (NYSE:IPI) today reported its results for the third quarter of 2023. Key Highlights for Third Quarter 2023 Financial & OperationalTotal sales of $54.5 million, which compares to $74.8 million in the third quarter of 2022, as potash and Trio® average net realized sales prices(1) decreased to $433 and $298 per ton, respectively. Net loss of $7.2 million (or $0.56 per diluted share), which compares to net income of $13.1 million (or $0.97 per diluted share) in the third quarter of 2022. Gross margin of $0.5 million, which compares to $26.8 million in the third quarter of 2022. Cash flow used in operations of $0.3 million, which compares to $14.1 million...

Continue reading

IO Biotech Announces Participation in Upcoming Investor Conferences

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, today announced its participation in the upcoming investor conferences: Event: Jefferies London Healthcare ConferenceLocation: LondonOne-on-one meetings: Wednesday, November 15, 2023Participants: Mai-Britt Zocca, PhD, President and CEO and Amy Sullivan, CFO Event: Piper Sandler 35th Healthcare ConferenceLocation: New York, New YorkFireside chat: Wednesday, November 29, 2023 at 4:30 pm ETPresenter: Mai-Britt Zocca, PhD, President & CEOWebcast link: https://event.webcasts.com/starthere.jsp?ei=1643140&tp_key=1d3631cba2 A webcast replay of the presentations will be available on IO Biotech’s website at www.iobiotech.com...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.